Belt da Hanya: Haɗin kai, Jituwa da Win-Win
samfurori

Kayayyaki

Sitagliptin Phosphate CAS: 654671-78-0 Mai Karu

Sitagliptin Phosphateshine farkon novel dipeptidyl peptidase IV inhibitor daga Merck don kula da nau'in ciwon sukari na 2 ba tare da kiba ba kuma abin da ya faru na hypoglycemia yayi kama da placebo.Sitagliptin yana aiki ta hanyar haɓaka tsarin incretin na jiki, wanda ke taimakawa wajen daidaita glucose ta hanyar cutar da ƙwayoyin β da α a cikin pancreas.


Cikakken Bayani

Tags samfurin

Aikace-aikace da Tasiri

Sitagliptin Phosphate shine mai hana trizolopyrazine dipeptidyl peptidase IV mai hanawa.Sitagliptin an amince da shi kwanan nan don maganin ciwon sukari na II. Sitagliptin phosphate shine dipeptidyl peptidase Ⅳ (DDP-4) mai hanawa rukunin magungunan da kamfanin Merck na Jamus ya haɓaka kuma da farko ya sami amincewar Hukumar Abinci da Magunguna ta Amurka don kula da nau'in 2. ciwon sukari, wani sabon maganin ciwon sukari ne, yana iya inganta ikon jiki don rage yawan matakan glucose na jini, da kuma ƙara haɓakar haɓakar incretin ta dabi'a ta hanyar hana ayyukan wannan enzyme, gami da matakan glucagon-kamar peptide 1 da insulinotropic mai dogaro da glucose. peptide, don haka yana haifar da pancreas don inganta samar da insulin da kuma dakatar da samar da glucose a cikin hanta, kuma a ƙarshe ya rage tasirin tasirin glucose na jini.

Samfurin Samfura

shafi 364 (1)
shafi 365 (1)

Shirya samfur:

shafi 338 (1)

Ƙarin Bayani:

Abun ciki C16H15F6N5O.H3PO4
Assay 99%
Bayyanar Fari zuwa Kashe-Farin foda
CAS No. 654671-78-0
Shiryawa 25KG
Rayuwar Rayuwa shekaru 2
Adana Ajiye a wuri mai sanyi da bushewa
Takaddun shaida ISO.

  • Na baya:
  • Na gaba:

  • Ku rubuta sakonku anan ku aiko mana